Abstract:Hepatocellular carcinoma (HCC) is one of the deadliest cancers worldwide due to the lack of effective therapy methods. Therefore, there is an urgent need to develop novel therapies for HCC. CBL0137 is a small molecule that affects p53 and nuclear factor-kappa B (NF-κB). The expression of p53 was measured by using immunohistochemistry (IHC) in tumor and adjacent tissues. Western blotting (WB) and quantitative real-time polymerase chain reaction (qRT-PCR) were employed to detect the level of p-p53, p53, Bax, and PUMA after CBL0137 administration. CCK-8 and immunofluorescence staining (IF) assays were performed to evaluate the proliferation and viability of HCC cells. Flow cytometry was used to detect the apoptosis of HCC cells. Xenograft model was established to determine the effect of CBL0137 treatment on HCC tumor growth in vivo. HE staining was used to monitor HCC cell morphology and IHC staining for Ki-67 was performed to determine the tumor cell proliferation following CBL0137 treatment. Results showed that the expression of p-p53, p53, Bax, and PUMA was upregulated after CBL0137 administration. The viability, growth, and colony formation of HCC cells were significantly inhibited by CBL0137 in the CBL group compared with the NC group (p<0.05). Meanwhile, the results revealed that the proportions of apoptotic and necrotic cells were significantly elevated in the CBL group compared to the NC group (p<0.05). And the apoptosis-related proteins including PARP, caspase-3, caspase-7, caspase-8, and caspase-9 were increased in the CBL group compared with the NC group (p<0.05), while the NF-κB, p-NF-κB and p-AKT expression levels were significantly downregulated following CBL0137 treatment (p<0.05). Additionally, the tumor volume and weight were significantly reduced in the CBL group compared with the NC group (p<0.05). Moreover, HE staining and IHC staining for Ki-67 indicated that CBL0137 treatment could obviously induce cell apoptosis and suppress cell proliferation. CBL0137 treatment could effectively inhibit HCC cell proliferation and induce cell apoptosis associated with multiple factors expression.

Differential Gene Exprisssion in Human Hepatocellular Carcinoma Hep38 Cells Indeced by Aptptosis-Related Gene BNIPL-2

Differential Gene Expression in Human Hepatocellular Carcinoma Hep3B Cells Induced by Apoptosis-Related Genebnipl-2

cDNA expression array analysis of gene expression in human hepatocarcinoma Hep3B cells induced by BNIPL-1.

Acetyl-Coenzyme A acyltransferase 2 attenuates the apoptotic effects of BNIP3 in two human cell lines.

Genes Encoding Pir51, Beclin 1, RbAp48 and Aldolase B Are Up or Down-Regulated in Human Primary Hepatocellular Carcinoma.

The apoptosis-associated protein BNIPL interacts with two cell proliferation-related proteins, MIF and GFER.

Primary Study of the Function of a Novel Gene BC047440 Highly Expressed in Human Hepatocellular Carcinoma

BC047440 Antisense Eukaryotic Expression Vectors Inhibited HepG2 Cell Proliferation and Suppressed Xenograft Tumorigenicity.

Nkx3.1 and P27kip1cooperate in Proliferation Inhibition and Apoptosis Induction in Human Androgen–Independent Prostate Cancer Cells

Expression of recombinant BC047440 protein and its effects on proliferation of HepG2 cells in vitro

BNIPL-2 promotes the invasion and metastasis of human hepatocellular carcinoma cells.

Pim-2 Activates API-5 to Inhibit the Apoptosis of Hepatocellular Carcinoma Cells Through NF-κB Pathway

Influence of Apoptin on Up-Regulation of the Expression of Bad and Bax

Effect of NUP88 gene on proliferation and invasion biological behavior of breast cancer cell line BT-20

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

Expressions of Nucleoside Diphosphate Kinase (nm23) in Tumor Tissues Are Related with Metastasis and Length of Survival of Patients with Hepatocellular Carcinoma

[Effects of the Novel Gene, LAPTM4B, Highly Expression in Hepatocellular Carcinoma on Cell Proliferation and Tumorigenesis of NIH3T3 Cells].

Identification of FN1BP1 As a Novel Cell Cycle Regulator Through Modulating G1 Checkpoint in Human Hepatocarcinoma Hep3B Cells

[Gene Apoptosis Expression Profiles in Liver Cancer and Their Comparison to Normal Peri-Cancerous Liver Tissues].

[Effects of Two Haplotypes of HCAP1 Gene on Cellular Gene Expression Levels in a Human Hepatocarcinoma Cell Line Hep3B].

Downregulation of Peptidylprolyl Isomerase A Promotes Cell Death and Enhances Doxorubicin-Induced Apoptosis in Hepatocellular Carcinoma.